A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer (Q33368219)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer |
scientific article |
Statements
1 reference
A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer (English)
1 reference
Branimir I Sikic
1 reference
Ranjana Advani
1 reference
Bert L Lum
1 reference
George A Fisher
1 reference
Joanne Halsey
1 reference
Richard S Geary
1 reference
Jon T Holmlund
1 reference
T Jesse Kwoh
1 reference
F Andrew Dorr
1 reference
1 October 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference